Immunotherapy improves survival of patients with locally advanced head and neck cancer
An international phase 3 clinical trial led by Washington University School of Medicine in St. Louis and Dana-Farber Brigham Cancer Center shows that patients with certain locally advanced head and neck cancers benefited from the addition of the...
26-Apr-2025 12:00 AM EDT
Add to Favorites